Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Regulation of paclitaxel sensitivity in prostate cancer cells by PTEN/maspin signaling.

Gan Y, Chen Q, Lei Y.

Oncol Lett. 2017 Oct;14(4):4977-4982. doi: 10.3892/ol.2017.6793. Epub 2017 Aug 23.

2.

Maspin impairs the function of endothelial cells: an implying pathway of preeclampsia.

Zhang Y, Liu H, Shi X, Qiao F, Zeng W, Feng L, Deng D, Liu H, Wu Y.

BMC Pregnancy Childbirth. 2017 Sep 29;17(1):328. doi: 10.1186/s12884-017-1525-z.

3.
4.

The Role of Angiogenesis in Cancer Treatment.

Rajabi M, Mousa SA.

Biomedicines. 2017 Jun 21;5(2). pii: E34. doi: 10.3390/biomedicines5020034. Review.

5.

The Opportunity of Precision Medicine for Breast Cancer With Context-Sensitive Tumor Suppressor Maspin.

Bernardo MM, Dzinic SH, Matta MJ, Dean I, Saker L, Sheng S.

J Cell Biochem. 2017 Jul;118(7):1639-1647. doi: 10.1002/jcb.25969. Epub 2017 Mar 21. Review.

PMID:
28262971
6.

Antitumor activity of miR-34a in peritoneal mesothelioma relies on c-MET and AXL inhibition: persistent activation of ERK and AKT signaling as a possible cytoprotective mechanism.

El Bezawy R, De Cesare M, Pennati M, Deraco M, Gandellini P, Zuco V, Zaffaroni N.

J Hematol Oncol. 2017 Jan 18;10(1):19. doi: 10.1186/s13045-016-0387-6.

7.

The secretion and biological function of tumor suppressor maspin as an exosome cargo protein.

Dean I, Dzinic SH, Bernardo MM, Zou Y, Kimler V, Li X, Kaplun A, Granneman J, Mao G, Sheng S.

Oncotarget. 2017 Jan 31;8(5):8043-8056. doi: 10.18632/oncotarget.13302.

8.

Expression patterns of maspin and mutant p53 are associated with the development of gestational trophoblastic neoplasia.

Sun P, Wu Q, Ruan G, Zheng X, Song Y, Zhun J, Wu L, Gotlieb WH.

Oncol Lett. 2016 Nov;12(5):3135-3142. Epub 2016 Sep 1.

9.

SERPINA4 is a novel independent prognostic indicator and a potential therapeutic target for colorectal cancer.

Sun HM, Mi YS, Yu FD, Han Y, Liu XS, Lu S, Zhang Y, Zhao SL, Ye L, Liu TT, Yang DH, Sun XF, Qin XB, Zhou ZG, Tang HM, Peng ZH.

Am J Cancer Res. 2016 Aug 1;6(8):1636-49. eCollection 2016.

10.

Nuclear IKK╬▒ mediates microRNA-7/-103/107/21 inductions to downregulate maspin expression in response to HBx overexpression.

Chen WS, Liu LC, Yen CJ, Chen YJ, Chen JY, Ho CY, Liu SH, Chen CC, Huang WC.

Oncotarget. 2016 Aug 30;7(35):56309-56323. doi: 10.18632/oncotarget.10462.

11.

Renin-angiotensin system gene polymorphisms and endometrial cancer.

Pringle KG, Delforce SJ, Wang Y, Ashton KA, Proietto A, Otton G, Blackwell CC, Scott RJ, Lumbers ER.

Endocr Connect. 2016 May;5(3):128-35. doi: 10.1530/EC-15-0112. Epub 2016 Apr 11.

12.

Maspin enhances cisplatin chemosensitivity in bladder cancer T24 and 5637 cells and correlates with prognosis of muscle-invasive bladder cancer patients receiving cisplatin based neoadjuvant chemotherapy.

Chen J, Wang L, Tang Y, Gong G, Liu L, Chen M, Chen Z, Cui Y, Li C, Cheng X, Qi L, Zu X.

J Exp Clin Cancer Res. 2016 Jan 6;35:2. doi: 10.1186/s13046-015-0282-y.

13.

Promoter Hypomethylation of Maspin Inhibits Migration and Invasion of Extravillous Trophoblast Cells during Placentation.

Shi X, Liu H, Cao J, Liu Q, Tang G, Liu W, Liu H, Deng D, Qiao F, Wu Y.

PLoS One. 2015 Aug 11;10(8):e0135359. doi: 10.1371/journal.pone.0135359. eCollection 2015.

14.

Pachymic acid modified carbon nanoparticles reduced angiogenesis via inhibition of MMP-3.

Ma J, Liu J, Lu CW, Cai DF.

Int J Clin Exp Pathol. 2015 May 1;8(5):5464-70. eCollection 2015.

15.

Maspin as a tumour suppressor in salivary gland tumour.

Tarakji B, Ashok N, Sheirawan MK, Altamimi MA, Alenzi F, Azzeghaiby SN, Baroudi K, Nassani MZ.

J Clin Diagn Res. 2014 Dec;8(12):ZE05-7. doi: 10.7860/JCDR/2014/9124.5241. Epub 2014 Dec 5. Review.

16.

Src phosphorylation converts Mdm2 from a ubiquitinating to a neddylating E3 ligase.

Batuello CN, Hauck PM, Gendron JM, Lehman JA, Mayo LD.

Proc Natl Acad Sci U S A. 2015 Feb 10;112(6):1749-54. doi: 10.1073/pnas.1416656112. Epub 2015 Jan 26.

17.

Supramolecular assembly of multifunctional maspin-mimetic nanostructures as a potent peptide-based angiogenesis inhibitor.

Zha RH, Sur S, Boekhoven J, Shi HY, Zhang M, Stupp SI.

Acta Biomater. 2015 Jan;12:1-10. doi: 10.1016/j.actbio.2014.11.001. Epub 2014 Nov 8.

18.

Maspin expression in prostate tumor elicits host anti-tumor immunity.

Dzinic SH, Chen K, Thakur A, Kaplun A, Bonfil RD, Li X, Liu J, Bernardo MM, Saliganan A, Back JB, Yano H, Schalk DL, Tomaszewski EN, Beydoun AS, Dyson G, Mujagic A, Krass D, Dean I, Mi QS, Heath E, Sakr W, Lum LG, Sheng S.

Oncotarget. 2014 Nov 30;5(22):11225-36.

19.
20.

Adaptive evolution and divergence of SERPINB3: a young duplicate in great Apes.

Gomes S, Marques PI, Matthiesen R, Seixas S.

PLoS One. 2014 Aug 18;9(8):e104935. doi: 10.1371/journal.pone.0104935. eCollection 2014.

Supplemental Content

Support Center